Key result
Cardiac rehabilitation faces substantial economic barriers to access across the Americas.
Why the study?
Although recommended and covered by payers, cardiac rehabilitation uptake remains low, partly due to substantial economic barriers across patients, clinicians, health systems, and payers.
This review highlights the economic barriers to cardiac rehabilitation access and emphasizes the need for strategies to optimize supply and demand across the Americas.
Answers are grounded in this paper and cite their sources.
Economic barriers limit cardiac rehabilitation access; leaves open optimal implementation strategies for future research.
Cardiac rehabilitation (CR) is an effective strategy for the secondary prevention of cardiovascular disease in individuals living with ischemic heart disease or heart failure, and among patients who have recently undergone cardiovascular surgery. Although CR is recommended by clinical guidelines and typically covered by payers, its uptake has been low. This is in part because of substantial economic barriers to accessing CR. Understanding the economics of CR from the perspective of various stakeholders -including patients, clinicians, health systems, and payers - is critical to developing strategies that optimize CR supply and demand, and increase uptake among populations most likely to benefit from this therapy. In this review, we summarize the currently available evidence, highlight current knowledge gaps, and identify key questions that should be prioritized in future research to guide the implementation of CR delivery.
No takes yet. Share an insight, caveat, or question.
Decker et al. (2025) conducted a review in Cardiovascular disease. Cardiac rehabilitation was evaluated. Cardiac rehabilitation faces substantial economic barriers to access across the Americas, necessitating future research to optimize supply and demand and increase uptake.
Synapse has enriched 10 related papers. Consider them for comparative context: